Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01969188 · ClinicalTrials.gov registry record
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
A clinical trial of Spondyloarthritis, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT01969188 is a study of Spondyloarthritis that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01969188, a study of Spondyloarthritis, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Spondyloarthritis refers to a set of inflammatory disorders that mainly afflict the spine, joints and ligaments. A subtype of spondyloarthritis is Ankylosing Spondylitis - now known as axial spondyloarthropathy - which is characterized by inflammation of the joints in the spinal column, and the part of the back where the spine meets the pelvis. Another subtype of spondyloarthritis is Psoriatic Arthritis where patients often develop raised patches of reddened skin. The disease can advance to one of more joints in the body resulting in pain, swelling and stiffness. These forms of inflammatory arthritis can become chronic and over time can lead to pain, disability and deformity. There is now evidence that patients with inflammatory arthritis that are diagnosed and treated earlier in the course of their symptoms may have better results. Yet although we know that early treatment is important, the investigators still don't know if there are factors that can predict how an individual patient's disease will progress over time in terms of losing mobility. The investigators also do not know the relationship between loosing mobility and the formation of bone around the spine and joints. The investigators are doing this study because the investigators want to learn more about patients with these forms of arthritis - Ankylosing Spondylitis and Psoriatic Arthritis. The investigators want to learn more about the factors that can predict how their disease might progress over time and what their response to treatment might be. The investigators would also like to determine the proportion of patients with these types of symptoms and describe the best treatment strategies for them.
Conditions Studied
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2013-01 |
| Est. Completion | 2025-12-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01969188
The ClinicalTrials.gov registry entry for NCT01969188 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Spondyloarthritis appearing as the primary indexed condition, and to 0 interventions.
NCT01969188 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01969188 about?
NCT01969188 is a clinical study titled "A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement". Spondyloarthritis refers to a set of inflammatory disorders that mainly afflict the spine, joints and ligaments. A subtype of spondyloarthritis is Ankylosing Spondylitis - now known as axial spondyloarthropathy - which is characterized by inflammation of the joints in the spinal column, and the part...
What is the current status of trial NCT01969188?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2013-01. Estimated completion is 2025-12-18.
What conditions does trial NCT01969188 study?
This clinical trial studies the following conditions: Spondyloarthritis.
Who is sponsoring clinical trial NCT01969188?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01969188 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.